Back to Aptus Capital Advisors, LLC Aptus Capital Advisors, LLC

KAPAKAPA
6 quarters

Position history for Aptus Capital Advisors, LLCAptus Capital Advisors, LLC's holdings in KAIROS PHARMA LTD

Yes. Aptus Capital Advisors holds 44,286 shares of KAPA (Kairos Pharma), worth $16,993, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Aptus Capital Advisors has held KAPA since Q1 2025, across 6 quarterly 13F filings.

Current Value

$16,993

Current Shares

44,286

Total Value Change

-$24,468

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
44,286
0.0%
$16,9930.0%$2.69
0
2026-Q1
Unchanged
44,286
0.0%
$24,7560.0%$3.91
0
2025-Q4
Unchanged
44,286
0.0%
$31,4430.0%$4.97
0
2025-Q3
Unchanged
44,286
0.0%
$51,8150.0%$8.19
0
2025-Q2
Unchanged
44,286
0.0%
$31,3990.0%$4.96
0
2025-Q1
New
44,286
-
$41,4610.0%$6.55
28

Other major holders of KAPA: CITADEL ADVISORS LLC, VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used